This rapid diagnostic device for monitoring the abnormal growth of the endometrial tissue is expected to allow women to detect whether VEGFIL-6 are too high at home in a simplerapid manner. These two factors are also increasing in some gynecological cancers. Through the new device, it is convenient for women to self-monitoring women physiologically-relevant diseasespossible causes of abnormal bleeding in the future,seek appropriate medical treatment early.

There are no rapid screening products for VEGFIL-6 applied to the abnormal bleeding test. The technology focus is to increase the device detection limit. The rapid diagnostic device for self-monitoring the abnormal growth of the endometrial tissue is to detect both IL-6VEGF in vaginal discharge,will be the first medical product that can detect these two biomarkers at home.

In view of the fact that the endometrial cancer proportion in Taiwan has increased year by year, this rapid diagnostic device for self-monitoring the abnormal growth of the endometrial tissue can be used to clarify the high-risk group. It is also possible to provide a home screening IVD tool for women who are unable to seek medical care in time due to certain factors.